Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 1/2014

01.01.2014 | Assisted Reproduction Technologies

The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles

verfasst von: Anthony N. Imudia, Randi H. Goldman, Awoniyi O. Awonuga, Diane L. Wright, Aaron K. Styer, Thomas L. Toth

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the impact of elevated serum estradiol levels (EE2-defined as levels > 90th percentile) on the day of hCG administration during IVF on oocyte fertilization, embryo development, implantation, clinical pregnancy and miscarriage rates.

Methods

A total of 2,995 consecutive IVF cycles in 1,889 patients with non-donor oocyte retrieval resulting in fresh embryo transfer between 1/1/2005 and 12/31/2011 were analyzed. Cycles were stratified by serum E2 level on the day of hCG administration into those with levels >90th percentile and ≤ 90th percentile. Rates of normal fertilization, embryo development, positive pregnancy test, implantation, clinical pregnancy and spontaneous miscarriage were compared.

Results

Serum estradiol above the 90th percentile on the day of hCG administration was associated with a significantly lower rate of normal fertilization (68.6 ± 20 vs. 71.6 ± 21, p = 0.02) when compared with patients with a lower serum estradiol threshold. The proportion of embryos that progressed from 2PN to 6–8 cell on day 3 was not different between the two groups. Although rates of positive pregnancy test (55.2 % vs. 57 %), implantation (26.4 % vs. 28.5 %) and clinical pregnancy (45.5 % vs. 49.4 %) were lower in patients with a higher estradiol threshold, these differences were not statistically significant. Similarly, there was no difference in the spontaneous miscarriage rates between the two groups (8.4 % vs. 7.1 %).

Conclusions

Serum estradiol levels above the 90th percentile on the day of hCG administration is associated with lower oocyte fertilization rate; however, such levels do not impact embryo development, implantation, clinical pregnancy or spontaneous miscarriage rates.
Literatur
1.
Zurück zum Zitat Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28:220–50.PubMed Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28:220–50.PubMed
2.
Zurück zum Zitat Bohlmann MK, Fritzsching B, Luedders DW, Hornemann A, Gopel W, Poschl J, et al. Impact of assisted reproduction on obstetrics and neonatology. Z Geburtshilfe Neonatol. 2009;213:221–7.PubMedCrossRef Bohlmann MK, Fritzsching B, Luedders DW, Hornemann A, Gopel W, Poschl J, et al. Impact of assisted reproduction on obstetrics and neonatology. Z Geburtshilfe Neonatol. 2009;213:221–7.PubMedCrossRef
3.
Zurück zum Zitat Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, et al. Reproductive technologies and the risk of birth defects. New Engl J Med. 2012;366:1803–13.PubMedCrossRef Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, et al. Reproductive technologies and the risk of birth defects. New Engl J Med. 2012;366:1803–13.PubMedCrossRef
4.
Zurück zum Zitat Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb). 2010;13:19–27.CrossRef Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb). 2010;13:19–27.CrossRef
5.
Zurück zum Zitat Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.PubMedCrossRef Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.PubMedCrossRef
6.
Zurück zum Zitat McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009;146:138–48.PubMedCrossRef McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009;146:138–48.PubMedCrossRef
7.
Zurück zum Zitat Perri T, Chen R, Yoeli R, Merlob P, Orvieto R, Shalev Y, et al. Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet. 2001;18:245–9.PubMedCrossRef Perri T, Chen R, Yoeli R, Merlob P, Orvieto R, Shalev Y, et al. Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet. 2001;18:245–9.PubMedCrossRef
8.
Zurück zum Zitat Retzloff MG, Hornstein MD. Is intracytoplasmic sperm injection safe? Fertil Steril. 2003;80:851–9.PubMedCrossRef Retzloff MG, Hornstein MD. Is intracytoplasmic sperm injection safe? Fertil Steril. 2003;80:851–9.PubMedCrossRef
9.
Zurück zum Zitat Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. New Engl J Med. 2002;346:731–7.PubMedCrossRef Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. New Engl J Med. 2002;346:731–7.PubMedCrossRef
10.
Zurück zum Zitat Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P, et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167:778–84.PubMedCrossRef Tan SL, Doyle P, Campbell S, Beral V, Rizk B, Brinsden P, et al. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol. 1992;167:778–84.PubMedCrossRef
11.
Zurück zum Zitat Calhoun KC, Barnhart KT, Elovitz MA, Srinivas SK. Evaluating the association between assisted conception and the severity of preeclampsia. ISRN Obstet Gynecol. 2011;2011:928592.PubMedCentralPubMedCrossRef Calhoun KC, Barnhart KT, Elovitz MA, Srinivas SK. Evaluating the association between assisted conception and the severity of preeclampsia. ISRN Obstet Gynecol. 2011;2011:928592.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Farhi J, Ben-Haroush A, Andrawus N, Pinkas H, Sapir O, Fisch B, et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online. 2010;21:331–7.PubMedCrossRef Farhi J, Ben-Haroush A, Andrawus N, Pinkas H, Sapir O, Fisch B, et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online. 2010;21:331–7.PubMedCrossRef
13.
Zurück zum Zitat Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97:1374–9.PubMedCrossRef Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97:1374–9.PubMedCrossRef
14.
Zurück zum Zitat Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95:115–28.CrossRef Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95:115–28.CrossRef
15.
Zurück zum Zitat Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, et al. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand. 2007;86:849–54.PubMedCrossRef Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, et al. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand. 2007;86:849–54.PubMedCrossRef
16.
Zurück zum Zitat Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril. 1988;49:118–22.PubMed Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril. 1988;49:118–22.PubMed
17.
Zurück zum Zitat O’Neill C, Ferrier AJ, Vaughan J, Sinosich MJ, Saunders DM. Causes of implantation failure after in-vitro fertilisation and embryo transfer. Lancet. 1985;2:615.PubMedCrossRef O’Neill C, Ferrier AJ, Vaughan J, Sinosich MJ, Saunders DM. Causes of implantation failure after in-vitro fertilisation and embryo transfer. Lancet. 1985;2:615.PubMedCrossRef
18.
Zurück zum Zitat Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190–5.PubMed Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190–5.PubMed
19.
Zurück zum Zitat Chen QJ, Sun XX, Li L, Gao XH, Gemzell-Danielsson K, Cheng LN. Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase. Fertil Steril. 2008;89:1357–63.PubMedCrossRef Chen QJ, Sun XX, Li L, Gao XH, Gemzell-Danielsson K, Cheng LN. Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri-implantation phase. Fertil Steril. 2008;89:1357–63.PubMedCrossRef
20.
Zurück zum Zitat Gelety TJ, Buyalos RP. The influence of supraphysiologic estradiol levels on human nidation. J Assist Reprod Genet. 1995;12:406–12.PubMedCrossRef Gelety TJ, Buyalos RP. The influence of supraphysiologic estradiol levels on human nidation. J Assist Reprod Genet. 1995;12:406–12.PubMedCrossRef
21.
Zurück zum Zitat Gratton RJ, Nisker JA, Daniel S, Toth S, Gunter J, Kaplan BR, et al. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates. Hum Reprod. 1993;8:528–31.PubMed Gratton RJ, Nisker JA, Daniel S, Toth S, Gunter J, Kaplan BR, et al. An aggressive philosophy in controlled ovarian stimulation cycles increases pregnancy rates. Hum Reprod. 1993;8:528–31.PubMed
22.
Zurück zum Zitat Levi AJ, Drews MR, Bergh PA, Miller BT, Scott Jr RT. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril. 2001;76:670–4.PubMedCrossRef Levi AJ, Drews MR, Bergh PA, Miller BT, Scott Jr RT. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril. 2001;76:670–4.PubMedCrossRef
23.
Zurück zum Zitat Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod. 1995;10:2432–7.PubMedCrossRef Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod. 1995;10:2432–7.PubMedCrossRef
24.
Zurück zum Zitat Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril. 1999;72:401–5.PubMedCrossRef Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril. 1999;72:401–5.PubMedCrossRef
25.
Zurück zum Zitat Tarin JJ, Sampaio MC, Calatayud C, Castellvi RM, Bonilla-Musoles F, Pellicer A. Relativity of the concept ‘high responder to gonadotrophins’. Hum Reprod. 1992;7:19–22.PubMedCrossRef Tarin JJ, Sampaio MC, Calatayud C, Castellvi RM, Bonilla-Musoles F, Pellicer A. Relativity of the concept ‘high responder to gonadotrophins’. Hum Reprod. 1992;7:19–22.PubMedCrossRef
26.
Zurück zum Zitat Ehrlich S, Williams PL, Missmer SA, Flaws JA, Ye X, Calafat AM, et al. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod. 2012;27:3583–92.PubMedCrossRef Ehrlich S, Williams PL, Missmer SA, Flaws JA, Ye X, Calafat AM, et al. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod. 2012;27:3583–92.PubMedCrossRef
27.
Zurück zum Zitat Styer AK, Wright DL, Wolkovich AM, Veiga C, Toth TL. Single-blastocyst transfer decreases twin gestation without affecting pregnancy outcome. Fertil Steril. 2008;89:1702–8.PubMedCrossRef Styer AK, Wright DL, Wolkovich AM, Veiga C, Toth TL. Single-blastocyst transfer decreases twin gestation without affecting pregnancy outcome. Fertil Steril. 2008;89:1702–8.PubMedCrossRef
28.
Zurück zum Zitat Pellicer A, Ruiz A, Castellvi RM, Calatayud C, Ruiz M, Tarin JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod. 1989;4:536–40.PubMed Pellicer A, Ruiz A, Castellvi RM, Calatayud C, Ruiz M, Tarin JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod. 1989;4:536–40.PubMed
29.
Zurück zum Zitat Tarin JJ, Pellicer A. Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril. 1990;54:665–70.PubMed Tarin JJ, Pellicer A. Consequences of high ovarian response to gonadotropins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril. 1990;54:665–70.PubMed
30.
Zurück zum Zitat Testart J, Belaisch-Allart J, Forman R, Gazengel A, Strubb N, Hazout A, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum Reprod. 1989;4:192–7.PubMed Testart J, Belaisch-Allart J, Forman R, Gazengel A, Strubb N, Hazout A, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum Reprod. 1989;4:192–7.PubMed
31.
Zurück zum Zitat Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N, et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. Hum Reprod. 1989;4:198–201.PubMed Testart J, Forman R, Belaisch-Allart J, Volante M, Hazout A, Strubb N, et al. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone. Hum Reprod. 1989;4:198–201.PubMed
32.
Zurück zum Zitat Harrod SB, Lacy RT, Morgan AJ. Offspring of prenatal IV nicotine exposure exhibit increased sensitivity to the reinforcing effects of methamphetamine. Front Pharmacol. 2012;3:116.PubMedCentralPubMedCrossRef Harrod SB, Lacy RT, Morgan AJ. Offspring of prenatal IV nicotine exposure exhibit increased sensitivity to the reinforcing effects of methamphetamine. Front Pharmacol. 2012;3:116.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6:e15997.CrossRef Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6:e15997.CrossRef
34.
Zurück zum Zitat Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, et al. Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. J Thorac Cardiovasc Surg. 2009;137:1468–74.PubMedCrossRef Turer AT, Mahaffey KW, Honeycutt E, Tuttle RH, Shaw LK, et al. Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. J Thorac Cardiovasc Surg. 2009;137:1468–74.PubMedCrossRef
35.
Zurück zum Zitat Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril. 1990;54:858–63.PubMed Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril. 1990;54:858–63.PubMed
36.
Zurück zum Zitat Chen CH, Zhang X, Barnes R, Confino E, Milad M, Puscheck E, et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003;80:75–9.PubMedCrossRef Chen CH, Zhang X, Barnes R, Confino E, Milad M, Puscheck E, et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003;80:75–9.PubMedCrossRef
Metadaten
Titel
The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles
verfasst von
Anthony N. Imudia
Randi H. Goldman
Awoniyi O. Awonuga
Diane L. Wright
Aaron K. Styer
Thomas L. Toth
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 1/2014
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-013-0117-8

Weitere Artikel der Ausgabe 1/2014

Journal of Assisted Reproduction and Genetics 1/2014 Zur Ausgabe

Editor’s Commentary

Next gen ARTs: what lies ahead?

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.